With 0.19 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.16 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $8.17 whereas the lowest price it dropped to was $7.91. The 52-week range on VMD shows that it touched its highest point at $10.44 and its lowest point at $6.21 during that stretch. It currently has a 1-year price target of $12.83. Beta for the stock currently stands at 1.46.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VMD was up-trending over the past week, with a rise of 1.50%, but this was down by -5.57% over a month. Three-month performance dropped to -3.55% while six-month performance rose 27.99%. The stock gained 11.66% in the past year, while it has gained 1.50% so far this year. A look at the trailing 12-month EPS for VMD yields 0.26 with Next year EPS estimates of 0.39. For the next quarter, that number is 0.10. This implies an EPS growth rate of 12.00% for this year and 40.48% for next year. EPS is expected to grow by 27.70% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 1.15%.
Float and Shares Shorts:
At present, 38.93 million VMD shares are outstanding with a float of 34.02 million shares on hand for trading. On 2024-12-13, short shares totaled 0.31 million, which was 79.00001 higher than short shares on 1731628800. In addition to Mr. Casey Hoyt as the firm’s CEO & Director, Mr. Michael B. Moore CRT serves as its President.
Institutional Ownership:
Through their ownership of 0.66628 of VMD’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, VMD reported revenue of $58004000.0 and operating income of $5159000.0. The EBITDA in the recently reported quarter was $11663000.0 and diluted EPS was $0.1.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With VMD analysts setting a high price target of 15.0 and a low target of 9.3, the average target price over the next 12 months is 12.26667. Based on these targets, VMD could surge 84.28% to reach the target high and rise by 14.25% to reach the target low. Reaching the average price target will result in a growth of 50.7% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.28849 being high and $0.26924 being low. For VMD, this leads to a yearly average estimate of $0.28.
